More Imugene Ltd news Imugene LtdASX: IMU Final HER-Vaxx Phase 2 Trial Overall Survival Results Jun 27, 2022 at 2:44 AM UTC · Issued by Imugene Ltd As issuedPlain English Imugene Ltd has released a press release. View Attachment
